EnPlusOne Biosciences
PrivateLast Round
VC Round
Feb 19, 2025
Total Funding Raised
$12M
Company Overview
EnPlusOne Biosciences is a biotechnology company that developed ezRNA™, an enzymatic-based RNA synthesis platform designed to manufacture RNA oligonucleotides for therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Pharma Supply Chain, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EnPlusOne Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
EnPlusOne Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 19, 2025 | ||||
| Seed | Sep 30, 2022 |
EnPlusOne Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northpond Ventures | VC Round, Seed |
| Breakout Ventures | Seed, VC Round |
| Coatue Management | Seed |
EnPlusOne Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EnPlusOne Biosciences's valuation, stock price, and market status.